Skip to main content
. 2023 Sep 5;13:14632. doi: 10.1038/s41598-023-41092-7

Figure 5.

Figure 5

Co-expression of EfAb promotes increased levels and enhances the half-life of serum VNA-TcdB. (a) Table summarizing the dosing and sampling schedule for gnotobiotic piglets in (b) and (c). †Termination of individual animals. In group 2, following Day 5, only a single animal remained in the study. (b) Quantification of VNA-TcdB levels in piglets (VHH detection ELISA) following a single intravenous injection of mRNA-LNP encoding VNA-TcdB, either together with mRNA-LNP encoding EfAb (depicted in Fig. 5c; n = 2) or a control mRNA-LNP (n = 2; n = 1 following day 5, control mRNA encoded a non-translated GFP) or VNA-TcdB alone (n = 1). Serum VNA-TcdB values were determined by VHH detection ELISA (Supplement Table 2). Data is depicted as mean. Error bars represent the SD of two replicates. (c) PK profile of co-administered EfAb in piglets which had received. a single intravenous injection of mRNA-LNP encoding EfAb together with mRNA-LNP encoding VNA-TcdB (depicted as lime group in Fig. 5b) were determined using Total human IgG ELISA (Supplement Table 3). Data is depicted as mean. Error bars represent the SD of two replicates.